U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients ...
Lilly’s drug that can slow Alzheimer’s disease has received the approval of the U.S. Food and Drug Administration; the ...
that target one contributor to Alzheimer’s — sticky amyloid plaque buildup in the brain. Questions remain about which ...
On July 2, the FDA also approved a look-alike competitor, Kisunla. Case closed, many scientists have argued, although drugs ...
FDA approves another Alzheimer’s drug that can modestly slow disease “The removal of the only authorized use of BVO from the ...
Cooling economic data raised rate-cut hopes. Eli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi (SNY) and Regeneron's Dupixent gets approval for COPD in ...
The FDA has approved a new Alzheimer's drug that offers hope for a slower cognitive decline. It's only the second drug that's ...
Patient assistance programs may actually be a two-way street, providing patients with drugs and companies with data.
İSTANBUL, Türkiye — USA defeated Italy 129-88 to win the FIBA U17 Basketball World Cup 2024 championship and complete their ...
All the Whitneys ask is that visitors make a donation to a good cause. (Submitted by Gail Whitney) Gail says they decided to ...
As Fort Worth grows, researchers across various medical institutions discuss the future of local clinical research and its ...